Tag: Greg Laub

Dec292024 by adminNo Comments

Incorporating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

Meeting Coverage > > ASH Expert Roundtable: Multiple Myeloma-- Experts weigh the function of MRD in customizing treatment however care versus early modifications by Greg Laub, Director, Video, MedPage Today December 28, 2024 At the American Society of Hematology yearly conference, a roundtable conversation highlighted the progressing function of very little recurring illness (MRD) as a treatment endpoint in several myeloma, exploring its ramifications for treatment escalation, de-escalation, and discontinuation. MedPage Today united 3 skilled leaders in the field: Moderator Joseph Mikhael, MD, is signed up with by Amrita Krish...

Feb292024 by adminNo Comments

More Data Support Olaparib-Abiraterone in BRCA-Mutant Prostate Cancer

Health and Mediacal

Meeting Coverage > > GuCS Video Pearls-- BRCAAway trial verifies function of mix in first-line setting by Greg Laub, Director, Video, MedPage Today February 15, 2024 Integrating olaparib (Lynparza) with abiraterone acetate (Zytiga) as first-line treatment for biomarker-selected clients with metastatic castration-resistant prostate cancer considerably enhanced progression-free survival (PFS) versus either representative alone, according to findings from a little stage II trial provided at this year's Genitourinary Cancers Symposium. In this special MedPage Today video, Daniel Geynisman, MD, of Fox Chase Cancer Center in Philadelphia, w...